OMGA
Price:
$1.04
Market Cap:
$57.36M
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regenera...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
OMGA
According to Omega Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.73. This represents a change of -60.96% compared to the average of -1.87 of the last 4 quarters.
The mean historical PE Ratio of Omega Therapeutics, Inc. over the last ten years is -15.76. The current -0.73 PE Ratio has changed 363.12% with respect to the historical average. Over the past ten years (40 quarters), OMGA's PE Ratio was at its highest in in the September 2023 quarter at -1.33. The PE Ratio was at its lowest in in the March 2020 quarter at -22.98.
Average
-15.76
Median
-7.83
Minimum
-41.31
Maximum
-1.67
Discovering the peaks and valleys of Omega Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -1.67
Minimum Annual Increase = -69.11%
Minimum Annual PE Ratio = -41.31
Year | PE Ratio | Change |
---|---|---|
2023 | -1.67 | -37.36% |
2022 | -2.66 | -65.98% |
2021 | -7.83 | -69.11% |
2020 | -25.34 | -38.64% |
The current PE Ratio of Omega Therapeutics, Inc. (OMGA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.05
5-year avg
-15.76
10-year avg
-15.76
Omega Therapeutics, Inc.’s PE Ratio is greater than PMV Pharmaceuticals, Inc. (-1.73), greater than Eliem Therapeutics, Inc. (-2.42), greater than MediciNova, Inc. (-10.09), greater than Pharvaris N.V. (-10.45), greater than PepGen Inc. (-2.47), greater than Olema Pharmaceuticals, Inc. (-6.09), greater than Nuvectis Pharma, Inc. (-5.05), greater than Larimar Therapeutics, Inc. (-7.46), greater than Centessa Pharmaceuticals plc (-11.03), greater than Orchestra BioMed Holdings, Inc. (-3.52), greater than Aerovate Therapeutics, Inc. (-0.89), greater than Enliven Therapeutics, Inc. (-16.05), greater than MoonLake Immunotherapeutics (-53.23), greater than Structure Therapeutics Inc. (-19.52), greater than Compass Therapeutics, Inc. (-5.11), greater than Mineralys Therapeutics, Inc. (-5.57), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.44),
Company | PE Ratio | Market cap |
---|---|---|
-1.73 | $84.49M | |
-2.42 | $342.68M | |
-10.09 | $82.40M | |
-10.45 | $1.29B | |
-2.47 | $221.28M | |
-6.09 | $679.18M | |
-5.05 | $117.70M | |
-7.46 | $483.02M | |
-11.03 | $1.80B | |
-3.52 | $206.52M | |
-0.89 | $78.52M | |
-16.05 | $1.31B | |
-53.23 | $2.92B | |
-19.52 | $2.27B | |
-5.11 | $233.90M | |
-5.57 | $671.31M | |
-2.44 | $15.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omega Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omega Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Omega Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Omega Therapeutics, Inc. (OMGA)?
What is the highest PE Ratio for Omega Therapeutics, Inc. (OMGA)?
What is the 3-year average PE Ratio for Omega Therapeutics, Inc. (OMGA)?
What is the 5-year average PE Ratio for Omega Therapeutics, Inc. (OMGA)?
How does the current PE Ratio for Omega Therapeutics, Inc. (OMGA) compare to its historical average?